Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: Implications for pathophysiology

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 4, 2009, Pages 213-220

  Green, Pnina ^a   Anyakoha, Ngozi ^c   Yadid, Gal ^b   Gispan Herman, Iris ^b   Nicolaou, Anna ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Arachidonic acid; Depression; Electrospray ionisation tandem mass spectrometry; Flinders Sensitive Line rats; High field NMR; Phosphatidylcholine

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; ESTERASE; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLSERINE; PLASMALOGEN; SPHINGOMYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; ENZYME ACTIVITY; ERYTHROCYTE; EXPERIMENTAL RAT; FLINDERS SENSITIVE LINE RAT; HYPOTHALAMUS; LIPID ANALYSIS; LIPID COMPOSITION; MALE; NEUROPATHY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; ARACHIDONIC ACID; BRAIN; CHOLESTEROL; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTES; MALE; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOMYELINS;

ANIMALIA; RATTUS;

EID: 67349265673     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.02.005     Document Type: Article

References (47)

1. Noaghiul S., and Hibbeln J.R. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am. J. Psychiatry 160 (2003) 2222-2227
2. Edwards R., Peet M., Shay J., and Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48 (1998) 149-155
3. Su K.P., Huang S.Y., Chiu C.C., and Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 13 (2003) 267-271
4. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck Jr. P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
5. Lin P.Y., and Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 68 (2007) 1056-1061
6. Green P., Gispan-Herman I., and Yadid G. Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression. J. Lipid Res. 46 (2005) 1093-1096
7. Muskiet F.A., and Kemperman R.F. Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J. Nutr. Biochem. 17 (2006) 717-727
8. Rao J.S., Lee H.J., Rapoport S.I., and Bazinet R.P. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?. Mol. Psychiatry (2008)
9. Vinod K.Y., and Hungund B.L. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27 (2006) 539-545
10. Overstreet D.H., Russell R.W., Helps S.C., and Messenger M. Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berlin) 65 (1979) 15-20
11. Russell R.W., Overstreet D.H., Messenger M., and Helps S.C. Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables. Pharmacol. Biochem. Behav. 17 (1982) 885-891
12. Overstreet D.H. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17 (1993) 51-68
13. Overstreet D.H., and Djuric V. A genetic rat model of cholinergic hypersensitivity: implications for chemical intolerance, chronic fatigue, and asthma. Ann. N Y Acad. Sci. 933 (2001) 92-102
14. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem. J. 114 (1969) 711-717
15. Zaccheo O., Dinsdale D., Meacock P.A., and Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J. Biol. Chem. 279 (2004) 24024-24033
16. Muhlig-Versen M., da Cruz A.B., Tschape J.A., Moser M., Buttner R., Athenstaedt K., Glynn P., and Kretzschmar D. Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J. Neurosci. 25 (2005) 2865-2873
17. Glynn P. A mechanism for organophosphate-induced delayed neuropathy. Toxicol. Lett. 162 (2006) 94-97
18. Fernandez-Murray J.P., and McMaster C.R. Phosphatidylcholine synthesis and its catabolism by yeast neuropathy target esterase 1. Biochim. Biophys. Acta 1771 (2007) 331-336
19. Malkesman O., Shayit M., Genud R., Zangen A., Kinor N., Maayan R., Weizman A., Weller A., and Yadid G. Dehydroepiandrosterone in the nucleus accumbens is associated with early onset of depressive-behavior: a study in an animal model of childhood depression. Neuroscience 149 (2007) 573-581
20. Dremencov E., Weizmann Y., Kinor N., Gispan-Herman I., and Yadid G. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response. Curr. Drug Targets 7 (2006) 165-175
21. Overstreet D.H., Friedman E., Mathe A.A., and Yadid G. The flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 29 (2005) 739-759
22. Zangen A., Overstreet D.H., and Yadid G. Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res. 824 (1999) 243-250
23. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
24. 1H-NMR lipid profiles of human blood platelets; links with coronary artery disease. Biochim. Biophys. Acta 1487 (2000) 15-23
25. Little S.J., Lynch M.A., Manku M., and Nicolaou A. Docosahexaenoic acid-induced changes in phospholipids in cortex of young and aged rats: a lipidomic analysis. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 155-162
26. Brugger B., Erben G., Sandhoff R., Wieland F.T., and Lehmann W.D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 94 (1997) 2339-2344
27. Hara A., and Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90 (1978) 420-426
28. Green P., and Yavin E. Natural and accelerated docosahexaenoic acid accumulation in the prenatal rat brain. Lipids 31 Suppl (1996) S235-S238
29. Nealon J.R., Blanksby S.J., Mitchell T.W., and Else P.L. Systematic differences in membrane acyl composition associated with varying body mass in mammals occur in all phospholipid classes: an analysis of kidney and brain. J. Exp. Biol. 211 (2008) 3195-3204
30. Marangoni F., Colombo C., and Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal. Biochem. 326 (2004) 267-272
31. Janowsky D.S., el-Yousef M.K., Davis J.M., and Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2 (1972) 632-635
32. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., and Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 33 (2003) 477-485
33. Glynn P. Neuropathy target esterase and phospholipid deacylation. Biochim. Biophys. Acta 1736 (2005) 87-93
34. Zangen A., Nakash R., Overstreet D.H., and Yadid G. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berlin) 155 (2001) 434-439
35. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem. Int. 48 (2006) 358-366
36. Kanterman R.Y., Ma A.L., Briley E.M., Axelrod J., and Felder C.C. Muscarinic receptors mediate the release of arachidonic acid from spinal cord and hippocampal neurons in primary culture. Neurosci. Lett. 118 (1990) 235-237
37. Felder C.C., Kanterman R.Y., Ma A.L., and Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. USA 87 (1990) 2187-2191
38. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., and Garnovskaya M.N. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 92 (2001) 179-212
39. Liu L., Barrett C.F., and Rittenhouse A.R. Arachidonic acid both inhibits and enhances whole cell calcium currents in rat sympathetic neurons. Am. J. Physiol. Cell Physiol. 280 (2001) C1293-C1305
40. 2+ current in sympathetic neurons. Proc. Natl. Acad. Sci. USA 100 (2003) 295-300
41. Barrett C.F., Liu L., and Rittenhouse A.R. Arachidonic acid reversibly enhances N-type calcium current at an extracellular site. Am. J. Physiol. Cell Physiol. 280 (2001) C1306-C1318
42. 2+ current and M-current by divergent signal transduction cascades. J. Neurosci. 26 (2006) 11588-11598
43. Arias H.R. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules. J. Neurosci. Res. 52 (1998) 369-379
44. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark Jr. E., Janowsky D.S., and Kling M.A. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berlin) 142 (1999) 193-199
45. Korade Z., and Kenworthy A.K. Lipid rafts, cholesterol, and the brain. Neuropharmacology 55 (2008) 1265-1273
46. Magnani F., Tate C.G., Wynne S., Williams C., and Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279 (2004) 38770-38778
47. Malkesman O., Braw Y., Maayan R., Weizman A., Overstreet D.H., Shabat-Simon M., Kesner Y., Touati-Werner D., Yadid G., and Weller A. Two different putative genetic animal models of childhood depression. Biol. Psychiatry 59 (2006) 17-23